Publications

  1. Tefferi A, Wassie EA, Guglielmelli P, Gangat N, Belachew AA, Lasho TL, Finke C, Ketterling RP, Hanson CA, Pardanani A, Wolanskyj AP, Maffioli M, Casalone R, Pacilli A, Vannucchi AM, Passamonti F. Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients. Am J Hematol. 2014 Aug; 89(8):E121-4. Epub 2014 May 16.
    View PubMed
  2. Gangat N, Wassie E, Lasho T, Finke C, Ketterling R, Hanson C, Pardanani A, Wolanskyj A, Maffioli M, Casalone R, Passamonti F, Tefferi A. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history. Eur J Haematol. 2014 Jun 03.
    View PubMed
  3. Tefferi A, Wassie EA, Lasho TL, Finke C, Belachew AA, Ketterling RP, Hanson CA, Pardanani A, Gangat N, Wolanskyj AP. Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia. 2014 May 05.
    View PubMed
  4. Roeker LE, Wolanskyj AP. Imatinib-associated melanosis of the palate. Am J Hematol. 2014 May; 89(5):564. Epub 2014 Mar 03.
    View PubMed
  5. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014 Apr; 89(4):484-92. Epub 2014 Feb 26.
    View PubMed
  6. Carlson AM, McPhail ED, Rodriguez V, Schroeder G, Wolanskyj AP. A prospective, randomized crossover study comparing direct inspection by light microscopy versus projected images for teaching of hematopathology to medical students. Anat Sci Educ. 2014 Mar; 7(2):130-4. Epub 2013 May 28.
    View PubMed
  7. Carlson AM, Mcphail ED, Rodriguez V, Schroeder G, Wolanskyj AP. A prospective, randomized crossover study comparing direct inspection by light microscopy versus projected images for teaching of hematopathology to medical students. Anat. sci. educ. 2014; 7(2):130-4.
  8. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Outcomes and Prognostic Factors in Adult Patients with Hemophagocytic Lymphohistiocytosis. Mayo Clinic Proceedings. 2014, Accepted.
  9. Gangat N, Wolanskyj AP. Anemia of chronic disease. Semin Hematol. 2013 Jul; 50(3):232-8.
    View PubMed
  10. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma. 2013 Jun; 54(6):1263-7. Epub 2012 Nov 19.
    View PubMed
  11. Roeker LE, Gupta V, Gonsalves WI, Wolanskyj AP, Gangat N. Cyclic bicytopenia in a patient with shapiro syndrome. Case Rep Hematol. 2013; 2013:231713. Epub 2013 Sep 25.
    View PubMed
  12. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook C, Kaufmann SH, Pruthi RK, Pardanani A, Begna KH, Ashrani AA, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy. Eur J Haematol. 2012 Mar; 88(3):237-43. Epub 2011 Nov 17.
    View PubMed
  13. Vaa BE, Wolanskyj AP, Roeker L, Pardanani A, Lasho TL, Finke CM, Tefferi A. Pruritus in primary myelofibrosis: clinical and laboratory correlates. Am J Hematol. 2012 Feb; 87(2):136-8. Epub 2011 Nov 12.
    View PubMed
  14. Spinner RJ, Vincent JF, Wolanskyj AP. Discovering the elusive Beauchene: the originator of the disarticulated anatomic technique. Clin Anat. 2011 Oct; 24(7):797-801. Epub 2011 Aug 26.
    View PubMed
  15. Thanarajasingam G, Vaidya R, Erie A, Wolanskyj AP. Accessory splenectomy for refractory immune thrombocytopenic purpura. Am J Hematol. 2011 Jun; 86(6):520-3. Epub 2011 Apr 25.
    View PubMed
  16. Baumann Kreuziger LM, Wolanskyj AP, Hanson CA, Steensma DP. Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts. Eur J Haematol. 2011 Jun; 86(6):512-6. Epub 2011 Apr 01.
    View PubMed
  17. Erie AJ, McClure RF, Wolanskyj AP. Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia. Hematol Rep. 2010 Jan 26; 2(1):e6. Epub 2010 Sep 24.
    View PubMed
  18. Pardanani A, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Hanson CA, Tefferi A. The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients. Leukemia. 2010 Jan; 24(1):110-4. Epub 2009 Oct 22.
    View PubMed
  19. Palmer SR, Thanarajasingam G, Wolanskyj AP. 39-year-old woman with an obscure case of anemia. Mayo Clin Proc. 2010 Jan; 85(1):e1-4.
    View PubMed
  20. Chee C, Tan T, Moynihan T, Wolanskyj AP. Training Program in Hematology-Oncology: Mayo Clinic Rochester Hematology-Oncology Fellowship. The American Journal of Hematology. 2010; 85(6):447-8 Epub 0.
  21. Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer. 2009 Dec 15; 115(24):5740-5.
    View PubMed
  22. Gangat N, Tefferi A, Thanarajasingam G, Patnaik M, Schwager S, Ketterling R, Wolanskyj AP. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance. Eur J Haematol. 2009 Jul; 83(1):17-21. Epub 2009 Feb 19.
    View PubMed
  23. Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol. 2009 May; 82(5):350-3. Epub 2009 Jan 06.
    View PubMed
  24. Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol. 2008 Nov; 35(11):2165-70. Epub 2008 Oct 15.
    View PubMed
  25. Spinner RJ, Vincent JF, Wolanskyj AP, Scheithauer BW. Intraneural ganglion cyst: a 200-year-old mystery solved. Clin Anat. 2008 Oct; 21(7):611-8.
    View PubMed
  26. Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, Mesa R, McClure RF, Li CY, Hanson CA. 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis. Eur J Haematol. 2008 May; 80(5):386-90. Epub 2008 Jan 23.
    View PubMed
  27. Spinner RJ, Amrami KK, Wolanskyj AP, Desy NM, Wang H, Benarroch EE, Skinner JA, Rock MG, Scheithauer BW. Dynamic phases of peroneal and tibial intraneural ganglia formation: a new dimension added to the unifying articular theory. J Neurosurg. 2007 Aug; 107(2):296-307.
    View PubMed
  28. Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer. 2007 Jun 1; 109(11):2279-84.
    View PubMed
  29. Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, Tefferi A. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia. 2007 Feb; 21(2):270-6. Epub 2006 Dec 14.
    View PubMed
  30. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG, Tefferi A. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006 Nov 15; 108(10):3472-6. Epub 2006 Jul 25.
    View PubMed
  31. Gangat N, Wolanskyj AP, Tefferi A. Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications. Eur J Haematol. 2006 Oct; 77(4):327-33. Epub 2006 Jul 19.
    View PubMed
  32. Pardanani A, Ketterling RP, Li CY, Patnaik MM, Wolanskyj AP, Elliott MA, Camoriano JK, Butterfield JH, Dewald GW, Tefferi A. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res. 2006 Aug; 30(8):965-70. Epub 2006 Jan 06.
    View PubMed
  33. Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia. Cancer. 2006 Jun 1; 106(11):2406-11.
    View PubMed
  34. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006 Feb; 81(2):159-66.
    View PubMed
  35. Tefferi A, Sirhan S, Lasho TL, Schwager SM, Li CY, Dingli D, Wolanskyj AP, Steensma DP, Mesa R, Gilliland DG. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia. Br J Haematol. 2005 Oct; 131(2):166-71.
    View PubMed
  36. Wolanskyj AP, Lasho TL, Schwager SM, McClure RF, Wadleigh M, Lee SJ, Gilliland DG, Tefferi A. JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance. Br J Haematol. 2005 Oct; 131(2):208-13.
    View PubMed
  37. Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, Witzig TE, Micallef IN, O'Neill BP. High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer. 2004 Jun 1; 100(11):2403-7.
    View PubMed
  38. Tefferi A, Lasho TL, Wolanskyj AP, Mesa RA. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood. 2004 May 1; 103(9):3547-8. Epub 2003 Dec 30.
    View PubMed
  39. Wolanskyj AP, Schroeder G, Wilson PR, Habermann TM, Inwards DJ, Witzig TE. A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. Clin Lymphoma. 2000 Sep; 1(2):154-7.
    View PubMed
  40. Fervenza FC, Wolanskyj AP, Eklund HE, Richardson RL. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clin Proc. 2000 Jan; 75(1):79-82.
    View PubMed
  41. Enesco H, Wolanskyj AP, Sawada M. Effect of copper on lifespan and lipid peroxidation in rotifers. Age. 1989; 12:9-23.
    View PubMed